Access a repository of CPPC’s case studies, reports, and original research. Our breadth of valuable information informs and guides your cannabis policy and research needs with a data-driven approach.
In January 2023, FDA announced that it would like to work with Congress to craft a legislative approach to the regulation of CBD products.
This report was ordered by the Oklahoma Medical Marijuana Authority (OMMA) to examine the supply chain and demand of the medical cannabis market…
STAY INFORMED ON CPPC'S RESEARCH AND PROJECTS